首页 › 伯基特淋巴瘤 › 明尼苏达州 › Minneapolis
Minneapolis MN 伯基特淋巴瘤临床试验
9项针对 伯基特淋巴瘤的研究正在 Minneapolis及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
招募中2 期
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
招募中3 期
- Abbott-Northwestern Hospital, Minneapolis
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
招募中2 期
- University of Minnesota/Masonic Cancer Center, Minneapolis
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
招募中1 期
- University of Minnesota, Minneapolis
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
招募中2 期
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
招募中3 期
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
招募中2 期
- Children's Hospitals and Clinics of Minnesota, Minneapolis
Allo HSCT Using RIC and PTCy for Hematological Diseases
招募中2 期
- Masonic Cancer Center at University of Minnesota, Minneapolis
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
招募中2 期
- Masonic Cancer Center at University of Minnesota, Minneapolis
其他城市的 伯基特淋巴瘤试验
- Houston, TX21 项研究
- Philadelphia, PA16 项研究
- Milwaukee, WI16 项研究
- Chicago, IL15 项研究
- Cincinnati, OH13 项研究
- New York City, NY13 项研究
- Atlanta, GA12 项研究
- Aurora, CO11 项研究
- Seattle, WA11 项研究
- Durham, NC10 项研究
- Boston, MA10 项研究
- Kansas City, MO10 项研究
Minneapolis的其他研究
- 非小细胞肺癌27 项研究
- 乳腺癌27 项研究
- 卵巢癌24 项研究
- 前列腺癌23 项研究
- 癌症（所有类型）22 项研究
- 心力衰竭21 项研究
- 急性髓系白血病20 项研究
- 肺癌20 项研究
- 结直肠癌19 项研究
- 子宫内膜癌18 项研究
- 帕金森病17 项研究
- 心血管疾病15 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。